gamma-Interferon-induced_JJ
resistance_NN
to_TO
1,25_CD
-_:
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2_CD
D3_NN
in_IN
human_JJ
monocytes_NNS
and_CC
macrophages_NNS
:_:
a_DT
mechanism_NN
for_IN
the_DT
hypercalcemia_NN
of_IN
various_JJ
granulomatoses_NNS
._.

The_DT
hypercalcemia_NN
of_IN
various_JJ
granulomatoses_NNS
is_VBZ
caused_VBN
by_IN
endogenous_JJ
1,25-dihydroxyvitamin_NN
D_NN
-LCB-_-LRB-
1,25_CD
-_:
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
-RCB-_-RRB-
overproduction_NN
by_IN
disease-activated_JJ
macrophages_NNS
._.

The_DT
inability_NN
of_IN
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
to_TO
suppress_VB
its_PRP$
synthesis_NN
in_IN
macrophages_NNS
contrasts_VBZ
with_IN
the_DT
tight_JJ
control_NN
of_IN
its_PRP$
production_NN
in_IN
macrophage_NN
precursors_NNS
,_,
peripheral_JJ
blood_NN
monocytes_NNS
-LRB-_-LRB-
PBM_NNS
-RRB-_-RRB-
._.

We_PRP
examined_VBD
whether_IN
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
resistance_NN
develops_VBZ
as_IN
PBM_NNS
differentiate_VBP
to_TO
macrophages_NNS
or_CC
with_IN
macrophage_NN
activation_NN
._.

Normal_JJ
human_JJ
pulmonary_JJ
alveolar_JJ
macrophages_NNS
-LRB-_-LRB-
PAM_NNS
-RRB-_-RRB-
are_VBP
less_RBR
sensitive_JJ
to_TO
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
than_IN
PBM_NNS
,_,
despite_IN
similar_JJ
vitamin_NN
D_NN
receptor_NN
content_NN
;_:
however_RB
,_,
both_CC
PBM_NNS
and_CC
PAM_NNS
respond_VBP
to_TO
exogenous_JJ
1,25_NN
-_:
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
by_IN
inhibiting_VBG
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
synthesis_NN
and_CC
inducing_VBG
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
degradation_NN
through_IN
enhancement_NN
of_IN
24-hydroxylase_NN
mRNA_NN
levels_NNS
and_CC
activity_NN
._.

The_DT
human_JJ
monocytic_JJ
cell_NN
line_NN
THP-1_NN
mimics_VBZ
PAM_NNS
in_IN
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
synthesis_NN
and_CC
sensitivity_NN
to_TO
exogenous_JJ
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
._.

We_PRP
utilized_VBD
THP-1_NN
cells_NNS
to_TO
examine_VB
the_DT
response_NN
to_TO
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
with_IN
macrophage_NN
activation_NN
._.

Activation_NN
of_IN
THP-1_NN
cells_NNS
with_IN
gamma-interferon_NN
-LRB-_-LRB-
gamma-IFN_NN
-RRB-_-RRB-
enhances_VBZ
1,25_JJ
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
synthesis_NN
30-fold_RB
,_,
blocks_VBZ
1,25_CD
-_NN
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
suppression_NN
of_IN
its_PRP$
synthesis_NN
,_,
and_CC
reduces_VBZ
by_IN
42.2_CD
%_NN
1,25_CD
-_:
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
induction_NN
of_IN
its_PRP$
degradation_NN
._.

The_DT
antagonistic_JJ
effects_NNS
of_IN
gamma-IFN_NN
are_VBP
not_RB
merely_RB
restricted_JJ
to_TO
enzymatic_JJ
activities_NNS
._.

In_IN
THP-1_NN
cells_NNS
and_CC
in_IN
normal_JJ
PBM_NNS
,_,
gamma-IFN_NN
inhibits_VBZ
1,25_CD
-_NN
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
induction_NN
of_IN
24-hydroxylase_NN
mRNA_NN
levels_NNS
without_IN
reducing_VBG
mRNA_NN
stability_NN
,_,
suggesting_VBG
gamma-IFN_NN
inhibition_NN
of_IN
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
transactivating_NN
function_NN
._.

These_DT
results_NNS
explain_VBP
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
overproduction_NN
in_IN
granulomatoses_NNS
and_CC
demonstrate_VBP
potent_JJ
inhibition_NN
by_IN
gamma-IFN_NN
of_IN
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
action_NN
in_IN
immune_JJ
cells_NNS
._.

